Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
World Journal of Hepatology|September 26, 2022
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenibVíctor Sapena, Massimo Iavarone, Loreto Boix, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2017
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated ApoptosisFrancesca Fornari, Daniela Pollutri, Clarissa Patrizi, et al.Cell Death Discovery|January 19, 2026
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancerSilvia Sabbioni, Paola Guerriero, Ram C Shankaraiah, et al.Journal of Hepatology|January 19, 2020
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogrammingMarta Anna Kowalik, Elisabetta Puliga, Lavinia Cabras, et al.International Journal of Molecular Sciences|March 29, 2019
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with MetforminSerena De Matteis, Emanuela Scarpi, Anna Maria Granato, et al.Oncotarget|April 11, 2018
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinomaFarzaneh Moshiri, Alessandro Salvi, Laura Gramantieri, et al.Cells|April 27, 2026
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular CarcinomaLaura Gramantieri, Clara Vianello, Ilaria Leoni, et al.Targeted Oncology|October 28, 2020
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaGiulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, et al.Targeted Oncology|October 12, 2020
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaGiulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE StudyAndrea Casadei-Gardini, Giorgia Marisi, Vincenzo Dadduzio, et al.Pageof 10